Oskar Slotboom
Director/Board Member at Varmx BV
Network origin in Oskar Slotboom first degree
Entity | Entity type | Industry | |
---|---|---|---|
Biogeneration Management BV
Biogeneration Management BV Investment ManagersFinance Biogeneration Management is a venture capital firm, a subsidiary of BioGeneration Holding BV and was founded in 2006. Biogeneration management is headquartered in Naarden.
14
| Subsidiary | Investment Managers | 14 |
Varmx BV
Varmx BV BiotechnologyHealth Technology VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018.
8
| Holding Company | Biotechnology | 8 |
Dunad Therapeutics Ltd.
Dunad Therapeutics Ltd. BiotechnologyHealth Technology Dunad Therapeutics Ltd. is a British biopharmaceutical company that specializes in developing targeted protein degradation therapies. Dunad was founded in 2020 and is headquartered in an undisclosed location, with operations in both the UK and the US. The company's platform allows for selective degradation through direct target modification using tuneable mono-valent small molecules, which enables the development of more drug-like, orally bioavailable, and CNS-accessible protein degraders. The company is backed by Epidarex Capital. Pearl Shirley Huang has been the CEO of the company since 2022.
5
| Holding Company | Biotechnology | 5 |
Mellon Medical BV
Mellon Medical BV Medical SpecialtiesHealth Technology Mellon Medical BV manufactures and develops surgical suturing devices. The firm’s suturing device, the Switch, is designed for surgeons who perform the challenging operations and can easily be rotated in the hand because of its pencil-like shape. The company was founded in April 2013 by Mark Vrancken Peeters and is headquartered in Nijmegen, the Netherlands.
3
| Holding Company | Medical Specialties | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Oskar Slotboom via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing | |
NOVADEL PHARMA INC | Pharmaceuticals: Major | Chief Executive Officer | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
ASANTE SOLUTIONS INC | Medical Specialties | Director/Board Member | |
BMEYE BV
BMEYE BV Electronic Equipment/InstrumentsElectronic Technology BMEYE BV operates as a non-invasive cardiovascular monitoring company. The firm manufactures and distributes non-invasive technology, hemodynamic monitoring equipment and related medical devices. It offers finger arterial pressure and cardiac output technologies. The company was founded in April 2005 and is headquartered in Amsterdam, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member President Director/Board Member | |
AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Lundbeckfond Invest A/S
Lundbeckfond Invest A/S Investment ManagersFinance Lundbeckfond Invest A/S (Lundbeckfond Invest) is the investment management subsidiary of the Lundbeck Foundation in Denmark. Established in 1999, the firm is based in Copenhagen and manages the Lundbeck Foundation's investments, aiming for long-term, stable returns with moderate risk, such that the Foundation's net capital is not jeopardized and the Foundation is able to meet its commitments in terms of awarding grants and of laying a capital base for its subsidiaries. | Investment Managers | Director/Board Member | |
Lundbeck Foundation
Lundbeck Foundation Investment Trusts/Mutual FundsMiscellaneous Lundbeck Foundation maintains and expands the activities of the Lundbeck Group. It provides funding for scientific research. Its support of scientific activities takes place mainly through the financing of concrete scientific projects in the areas of biomedicine and natural sciences. The firm grants a number of stipends and fellowships, and also supports education and procurement activities in biomedical and natural sciences. The company was founded by Grete Lundbeck on March 4, 1954 and is headquartered in Copenhagen, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member | |
Global Healthcare Exchange LLC
Global Healthcare Exchange LLC Packaged SoftwareTechnology Services Global Healthcare Exchange LLC engages in the provision of supply chain automation services for the healthcare sector. It offers E-commerce; Contracting; AP Automation; Data Management; Business Intelligence; and Compliance and Credentialing solutions. The company was founded in 2000 and is headquartered in Louisville, CO. | Packaged Software | Founder | |
Dr. Reddy's Research & Development BV
Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
Technical University of Denmark | College/University | Graduate Degree | |
University of Amsterdam | College/University | Undergraduate Degree | |
Johnson & Johnson Medical Ltd.
Johnson & Johnson Medical Ltd. Medical SpecialtiesHealth Technology Johnson & Johnson Medical Ltd. manufactures and markets medical devices. The company offers intravenous catheters, wound care products, disposable surgical packs & gowns and skin care products. It also sells sutures and surgical products made by Ethicon. Johnson & Johnson Medical is headquartered in Ascot, UK. | Medical Specialties | Director/Board Member | |
University of Copenhagen | College/University | Doctorate Degree Graduate Degree | |
Erasmus University Rotterdam | College/University | Doctorate Degree Doctorate Degree | |
University of Utrecht | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
University of Groningen | College/University | Doctorate Degree Graduate Degree | |
PharmaCell BV
PharmaCell BV BiotechnologyHealth Technology PharmaCell BV manufactures cell therapy and regenerative medicine. The firm engages in human cell line development and manufacturing of bio pharmaceuticals. Its services include process research and development, project management, incoming logistics, incoming goods, manufacturing auto logous and allogeneic products, quality control, final formulation, release and outgoing logistics. The company was founded by René Lardenoije and Jan Thio in 2005 and is headquartered in Maastricht, the Netherlands. | Biotechnology | Chief Executive Officer | |
MediService AG
MediService AG Drugstore ChainsRetail Trade MediService AG is a mail service pharmacy. The company is headquartered in Zuchwil, Switzerland. | Drugstore Chains | President | |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ORCA Therapeutics BV
ORCA Therapeutics BV Pharmaceuticals: GenericHealth Technology ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands. | Pharmaceuticals: Generic | Director/Board Member | |
ProFibrix BV
ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Biotechnology | Director/Board Member | |
Mölnlycke Health Care, Inc.
Mölnlycke Health Care, Inc. Medical SpecialtiesHealth Technology Mölnlycke Health Care, Inc. provides single use surgical and wound care products and services to the health care sector. It also provides logistics, education support, cost control, and consulting services. The company was founded in 1997 and is headquartered in Oakville, Canada. | Medical Specialties | Chairman | |
BIOM'UP | Medical Specialties | Chairman Director/Board Member | |
INKEF Capital BV
INKEF Capital BV Investment ManagersFinance INKEF Capital BV is an Independent Venture Capital firm founded in 2010 by Frank R Landsberger. INKEF Capital BV is headquartered in Amsterdam. | Investment Managers | Private Equity Investor Private Equity Analyst | |
ViroClinics Biosciences BV
ViroClinics Biosciences BV Pharmaceuticals: MajorHealth Technology ViroClinics Biosciences BV engages in the provision of diagnostic and clinical trial solutions. It offers research and development, preclinical, clinical trial operation, diagnostic testing, virus discovery, and quality assurance services. The company was founded by Albert Osterhaus in 2001 and is headquartered in Rotterdam, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Sigmascreening BV
Sigmascreening BV Wholesale DistributorsDistribution Services Sigmascreening BV develops new diagnostic products for breast cancer screening. It offers its products to improve the digital mammography in the screening. The company was founded by Kees Grimbergen, Ard den Heeten and Emile Konps in July 2010 and is headquartered in Amsterdam, the Netherlands. | Wholesale Distributors | Director/Board Member | |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
SPERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
SurgVision BV
SurgVision BV Medical SpecialtiesHealth Technology SurgVision BV provides optical imaging camera systems. It develops integrated optical imaging platforms, including camera, software and target specific tracer, for specific disease areas like breast cancer surgery. The company was founded by Vasilis Ntziachristos and Ton van den Hoven in 2011 and is headquartered in 't Harde, the Netherlands. | Medical Specialties | Director/Board Member Chairman | |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Biotechnology | Chairman Director/Board Member | |
Scenic Biotech BV
Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Scenic Biotech BV is using genomics to develop innovative therapies for patients affected by severe diseases. The company was founded by Thijn Brummelkamp and Sebastian Nijman and is headquartered in Amsterdam, Netherlands. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Veritas Investments
Veritas Investments Financial ConglomeratesFinance Veritas Investments provides investment services. The private company is based in The Hague, Netherlands. The CEO of the Dutch company is Jan Hendrik Egberts. | Financial Conglomerates | Chief Executive Officer | |
Pelvitec BV
Pelvitec BV Medical DistributorsDistribution Services Pelvitec BV is a Dutch company that wholesales medical and dental equipment. The private company is based in Delft, Netherlands. | Medical Distributors | Director/Board Member | |
Nlc Investments Ltd.
Nlc Investments Ltd. Financial ConglomeratesFinance Nlc Investments Ltd. provides investment services. | Financial Conglomerates | Director/Board Member | |
Vaccinatiezorg BV
Vaccinatiezorg BV Medical/Nursing ServicesHealth Services Vaccinatiezorg BV provides infection prevention and related medical services. The private company is based in Ravenstein, Netherlands. The CEO of the Dutch company is Jan Hendrik Egberts. | Medical/Nursing Services | Chief Executive Officer | |
Rodger BV
Rodger BV Medical DistributorsDistribution Services Rodger BV is a Dutch company that wholesales medical and dental instruments. The private company is based in Denekamp, Netherlands. | Medical Distributors | Director/Board Member | |
Tens Health BV
Tens Health BV Miscellaneous Commercial ServicesCommercial Services Tens Health BV provides health consulting services. The private company is based in Ravenstein, Netherlands. | Miscellaneous Commercial Services | Director/Board Member | |
ONWARD MEDICAL N.V. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Dualyx NV
Dualyx NV Miscellaneous Commercial ServicesCommercial Services Dualyx NV is a biotech company based in Ghent, Belgium that focuses on developing novel Treg-based therapies for patients with difficult-to-treat autoimmune diseases. The CEO of the company is Wouter Verhoeven, and it is located in Zwijnaarde, Belgium. Dualyx has developed a pipeline of highly promising immune modulating programs, including DT-001, an antibody agonist program targeting the TNF receptor 2 (TNFR2), which is currently in IND-enabling studies. The Belgian company aims to create next-generation biologic drugs for autoimmunity therapies with novel mechanisms of action, lower toxicity, and improved patient outcomes than traditional therapeutics. The company was founded in 2020 by Luc van Rompaey in collaboration with Wurzburg University, Argenx, VIB, Ghent University, and KU Leuven. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Complement Therapeutics Ltd.
Complement Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Complement Therapeutics Ltd. develops medicines that target the complement system. The British company was founded by Richard Unwin, Simon J. Clark, and Paul Bishop. The CEO is Rafiq Hasan. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sound Bioventures Management ApS | Investment Managers | Founder | |
NewAmsterdam Pharma BV
NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer |
Statistics
International
Netherlands | 26 |
United States | 10 |
Denmark | 7 |
United Kingdom | 4 |
Switzerland | 3 |
Sectoral
Health Technology | 26 |
Consumer Services | 8 |
Finance | 6 |
Commercial Services | 5 |
Distribution Services | 4 |
Operational
Director/Board Member | 134 |
Chief Executive Officer | 31 |
Chairman | 28 |
Corporate Officer/Principal | 25 |
Private Equity Investor | 21 |
Most connected contacts
Insiders | |
---|---|
Jan Hendrik Egberts | 33 |
Michael Bonney | 32 |
John Paul de Koning | 21 |
Edward van Wezel | 20 |
Casper Breum | 18 |
Elizabeth Ann Roper | 16 |
Alexander Vos | 15 |
Pearl Shirley Huang | 13 |
Jan Öhrström | 13 |
Rob de Ree | 9 |
Jeffrey Lawson | 8 |
Willem Hazenberg | 7 |
Arnoud Dijkstra | 7 |
Daniela Couto | 7 |
Joost J. M. Holthuis | 7 |
- Stock Market
- Insiders
- Oskar Slotboom
- Company connections